Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, February 14, 2018
Recipharm has appointed Bernard Pluta to lead its new global development organization.
read more
Recipharm Karlskoga AB, specialized in the manufacture of semi-solid products, and Pharmanest
AB, a Stockholm-based pharmaceutical company specializing in developing products for local pain
relief in obstetrics and gynecology, are pleased to ...
read more
Recipharm will acquire Sanofi’s contract inhalation drug business and plant in the U.K.
read more
Thursday, November 20, 2014
The Pharmaceutical Contract Development and Manufacturing Organisation, Recipharm AB (publ) has acquired Lisbon based CDMO Lusomedicameta Sociedade Técnica Farmacêutica S.A.
read more
Global contract development and manufacturing organisation (CDMO), Recipharm, announced the acquisition of GenIbet, a Portuguese CDMO, specialising in the manufacture of biological clinical trial material and novel modalities such as viral vectors, ...
read more
Recipharm has achieved the new ISO 45001 certification at its Wasserburg facility in Germany.
read more
11 June 2013 - Recipharm AB is pleased to announce that it is working with Vectura Group plc to provide access to its licence for the regulatory dossier of Asmasal® for the Chinese regulatory authorities as part of the Chinese market approval process...
read more
La Loma, Tlalnepantla, Mexico, Real Clean Distribuciones SA de CV is voluntarily recalling all lots four hand sanitizers it manufactured.
read more
Following cGMP audit of QuVa Pharma's Sugar Land and Temple, Texas facilities, the California Board of Pharmacy has issued Outsource Facility licenses to both QuVa locations.
read more
Wednesday, September 27, 2017
QuVa Pharma has received FDA registration as a 503B facility for its Bloomsbury, New Jersey facility.
read more
Quotient Sciences, a drug development and manufacturing accelerator, completed major investments and expansions at its Nottingham, UK and Reading, UK, facilities to support the delivery of fully integrated drug development programs through the ...
read more
Tuesday, October 16, 2018
Quotient Sciences announces an expansion to its operations in the U.S. with the opening of a state-of-the-art, 45,000-square-foot facility located near Philadelphia, in Garnet Valley, Pa.
read more
Thursday, February 17, 2022
Quotient Sciences has integrated drug substance into its flagship Translational Pharmaceutics® platform. The newly integrated service unites drug substance, drug product and clinical testing activities all within a unified organization and under a ...
read more
Quotient Sciences, the drug development and manufacturing accelerator, announced a £6.3 million-pound investment in its recently acquired manufacturing facility in Alnwick, U.K. The investment will significantly expand Quotient’s drug substance ...
read more
Friday, November 17, 2017
Quotient Sciences has acquired Pharmaterials, a contract development and manufacturing organization.
read more